当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Henry James
It is still unclear whether obesity surgery (OS) increases cancer risk. The English National Health Service was the focus of our investigation into this connection. OS has been linked to an increased risk of developing colorectal cancer (CRC) in a population-based Swedish study. A review observational investigation of people who went through operating system (medical procedure partner) or determined to have heftiness, yet had no operating system (nomedical procedure companion) were distinguished utilizing Clinic Episode Insights. Linkage to data from the National Cancer Registration & Analysis Service and the Office of National Statistics, respectively, was used to determine subsequent diagnoses of CRC, breast, endometrial, kidney, lung, and endometrial cancer, as well as time "at risk." Standardized incidence ratios (SIR) were calculated in relation to OS. Of the 002 607 obese patients, 3.9% (n = 39 747) underwent OS. 237 people who were obese and did not have surgery developed CRC. 43 people with OS developed CRC, compared to none with no surgery. In both the surgical and nonsurgical cohorts, there was an increased risk of endometrial and kidney cancer. CRC risk is expanded in people analyzed as fat. A higher risk of CRC was not linked to previous obesity surgery. In any case, the operating system populace was little, with restricted follow-up. While the risk of endometrial and kidney cancers remained elevated following OS, the risk of breast cancer decreased following OS in comparison to the obese population that did not have surgery.